Moreover, KEGG analysis of these members and their co-expression genes revealed the top 10 enriched pathways, among which drug metabolism pathways were significantly enriched, indicating that the members of the SMC gene family could serve as drug targets for PAAD. Here, DYM is linked to pancreatic adenocarcinoma.